Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on January 26, 2006. Sunitinib was the first cancer drug simultaneously approved for two different indications.
This report elaborates on the current development of the Sunitinib Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Company 1
Company 2
Company 3
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
By Type:
50 mg Capsules
25 mg Capsules
By Application:
pNET
Kidney cancer
GIST
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Sunitinib Drug Market Overview 2018-2029
-
1.1 China Sunitinib Drug Industry Development Overview
-
1.2 China Sunitinib Drug Industry Development History
-
1.3 China Sunitinib Drug Industry Market Size (2018-2029)
-
1.4 China Sunitinib Drug Market Analysis by Type from Production Side
-
1.4.1 China Sunitinib Drug Production Volume, Production Value and Growth Rate of 50 mg Capsules (2018-2029)
-
1.4.2 China Sunitinib Drug Production Volume, Production Value and Growth Rate of 25 mg Capsules (2018-2029)
-
1.5 China Sunitinib Drug Market Analysis by Application from Consumption End
-
1.5.1 China Sunitinib Drug Sales Volume, Sales Value and Growth Rate of pNET (2018-2029)
-
1.5.2 China Sunitinib Drug Sales Volume, Sales Value and Growth Rate of Kidney cancer (2018-2029)
-
1.5.3 China Sunitinib Drug Sales Volume, Sales Value and Growth Rate of GIST (2018-2029)
-
1.6 China Sunitinib Drug Market Analysis by Region
-
1.6.1 North China Sunitinib Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Sunitinib Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Sunitinib Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Sunitinib Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Sunitinib Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Sunitinib Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Sunitinib Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Sunitinib Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Sunitinib Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Sunitinib Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Sunitinib Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Sunitinib Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Sunitinib Drug Industry Development
Chapter 3 Sunitinib DrugIndustry Chain Analysis
-
3.1 Sunitinib Drug Industry Chain
-
3.2 Sunitinib Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Sunitinib Drug Market
-
3.3 Sunitinib Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Sunitinib Drug Market
Chapter 4 China Sunitinib Drug Market, by Type
-
4.1 China Sunitinib Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Sunitinib Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Sunitinib Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Sunitinib Drug Production Volume and Growth Rate of 50 mg Capsules
-
4.5.2 China Sunitinib Drug Production Volume and Growth Rate of 25 mg Capsules
Chapter 5 China Sunitinib Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Sunitinib Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Sunitinib Drug Market Size and Growth Rate, by Application
-
5.5.1 China Sunitinib Drug Market Size and Growth Rate of pNET
-
5.5.2 China Sunitinib Drug Market Size and Growth Rate of Kidney cancer
-
5.5.3 China Sunitinib Drug Market Size and Growth Rate of GIST
Chapter 6 China Sunitinib Drug Market, by Region
-
6.1 China Sunitinib Drug Production Volume and Production Value, by Region
-
6.2 China Sunitinib Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Sunitinib Drug Market Analysis
-
7.1 North China Sunitinib Drug Market, by Type
-
7.2 North China Sunitinib Drug Market, by Application
Chapter 8 Central China Sunitinib Drug Market Analysis
-
8.1 Central China Sunitinib Drug Market, by Type
-
8.2 Central China Sunitinib Drug Market, by Application
Chapter 9 South China Sunitinib Drug Market Analysis
-
9.1 South China Sunitinib Drug Market, by Type
-
9.2 South China Sunitinib Drug Market, by Application
Chapter 10 East China Sunitinib Drug Market Analysis
-
10.1 East China Sunitinib Drug Market, by Type
-
10.2 East China Sunitinib Drug Market, by Application
Chapter 11 Northeast China Sunitinib Drug Market Analysis
-
11.1 Northeast China Sunitinib Drug Market, by Type
-
11.2 Northeast China Sunitinib Drug Market, by Application
Chapter 12 Southwest China Sunitinib Drug Market Analysis
-
12.1 Southwest China Sunitinib Drug Market, by Type
-
12.2 Southwest China Sunitinib Drug Market, by Application
Chapter 13 Northwest China Sunitinib Drug Market Analysis
-
13.1 Northwest China Sunitinib Drug Market, by Type
-
13.2 Northwest China Sunitinib Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 Company 1
-
14.1.1 Company 1 Company Profile
-
14.1.2 Company 1 Sunitinib Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Company 2
-
14.2.1 Company 2 Company Profile
-
14.2.2 Company 2 Sunitinib Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Company 3
-
14.3.1 Company 3 Company Profile
-
14.3.2 Company 3 Sunitinib Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Company 4
-
14.4.1 Company 4 Company Profile
-
14.4.2 Company 4 Sunitinib Drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Company 5
-
14.5.1 Company 5 Company Profile
-
14.5.2 Company 5 Sunitinib Drug Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Company 6
-
14.6.1 Company 6 Company Profile
-
14.6.2 Company 6 Sunitinib Drug Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Company 7
-
14.7.1 Company 7 Company Profile
-
14.7.2 Company 7 Sunitinib Drug Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Company 8
-
14.8.1 Company 8 Company Profile
-
14.8.2 Company 8 Sunitinib Drug Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Company 9
-
14.9.1 Company 9 Company Profile
-
14.9.2 Company 9 Sunitinib Drug Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Company 10
-
14.10.1 Company 10 Company Profile
-
14.10.2 Company 10 Sunitinib Drug Market Performance
-
14.10.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Sunitinib Drug Industry Research Conclusions
-
15.2 Sunitinib Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Sunitinib Drug Industry Market Size (2018-2029)
-
Figure China Sunitinib Drug Production Volume, Production Value and Growth Rate of 50 mg Capsules (2018-2029)
-
Figure China Sunitinib Drug Production Volume, Production Value and Growth Rate of 25 mg Capsules (2018-2029)
-
Figure China Sunitinib Drug Sales Volume, Sales Value and Growth Rate of pNET (2018-2029)
-
Figure China Sunitinib Drug Sales Volume, Sales Value and Growth Rate of Kidney cancer (2018-2029)
-
Figure China Sunitinib Drug Sales Volume, Sales Value and Growth Rate of GIST (2018-2029)
-
Figure North China Sunitinib Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Sunitinib Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Sunitinib Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Sunitinib Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Sunitinib Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Sunitinib Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Sunitinib Drug Market Size and Growth Rate from 2018-2029
-
Figure Sunitinib Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Sunitinib Drug Market Share by Type in 2018
-
Figure China Sunitinib Drug Market Share by Type in 2023
-
Figure China Sunitinib Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Sunitinib Drug Production Volume and Growth Rate of 50 mg Capsules (2018-2023)
-
Figure China Sunitinib Drug Production Volume and Growth Rate of 25 mg Capsules (2018-2023)
-
Figure China Sunitinib Drug Market Share by Application in 2018
-
Figure China Sunitinib Drug Market Share by Application in 2023
-
Figure China Sunitinib Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Sunitinib Drug Market Size and Growth Rate of pNET (2018-2023)
-
Figure China Sunitinib Drug Market Size and Growth Rate of Kidney cancer (2018-2023)
-
Figure China Sunitinib Drug Market Size and Growth Rate of GIST (2018-2023)
-
Table China Sunitinib Drug Production Volume by Region (2018-2023)
-
Table China Sunitinib Drug Production Volume Share by Region (2018-2023)
-
Figure China Sunitinib Drug Production Volume Share by Region (2018-2023)
-
Table China Sunitinib Drug Production Value by Region (2018-2023)
-
Table China Sunitinib Drug Production Value Share by Region (2018-2023)
-
Figure China Sunitinib Drug Production Value Share by Region (2018-2023)
-
Table China Sunitinib Drug Sales Volume by Region (2018-2023)
-
Table China Sunitinib Drug Sales Volume Share by Region (2018-2023)
-
Figure China Sunitinib Drug Sales Volume Share by Region (2018-2023)
-
Table China Sunitinib Drug Sales Value by Region (2018-2023)
-
Table China Sunitinib Drug Sales Value Share by Region (2018-2023)
-
Figure China Sunitinib Drug Sales Value Share by Region (2018-2023)
-
Table North China Sunitinib Drug Production Volume by Type (2018-2023)
-
Table North China Sunitinib Drug Production Volume Share by Type (2018-2023)
-
Figure North China Sunitinib Drug Production Volume Share by Type (2018-2023)
-
Table North China Sunitinib Drug Sales Volume by Application (2018-2023)
-
Table North China Sunitinib Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Sunitinib Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Sunitinib Drug Production Volume by Type (2018-2023)
-
Table Central China Sunitinib Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Sunitinib Drug Production Volume Share by Type (2018-2023)
-
Table Central China Sunitinib Drug Sales Volume by Application (2018-2023)
-
Table Central China Sunitinib Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Sunitinib Drug Sales Volume Share by Application (2018-2023)
-
Table South China Sunitinib Drug Production Volume by Type (2018-2023)
-
Table South China Sunitinib Drug Production Volume Share by Type (2018-2023)
-
Figure South China Sunitinib Drug Production Volume Share by Type (2018-2023)
-
Table South China Sunitinib Drug Sales Volume by Application (2018-2023)
-
Table South China Sunitinib Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Sunitinib Drug Sales Volume Share by Application (2018-2023)
-
Table East China Sunitinib Drug Production Volume by Type (2018-2023)
-
Table East China Sunitinib Drug Production Volume Share by Type (2018-2023)
-
Figure East China Sunitinib Drug Production Volume Share by Type (2018-2023)
-
Table East China Sunitinib Drug Sales Volume by Application (2018-2023)
-
Table East China Sunitinib Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Sunitinib Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Sunitinib Drug Production Volume by Type (2018-2023)
-
Table Northeast China Sunitinib Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Sunitinib Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Sunitinib Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Sunitinib Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Sunitinib Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Sunitinib Drug Production Volume by Type (2018-2023)
-
Table Southwest China Sunitinib Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Sunitinib Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Sunitinib Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Sunitinib Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Sunitinib Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Sunitinib Drug Production Volume by Type (2018-2023)
-
Table Northwest China Sunitinib Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Sunitinib Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Sunitinib Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Sunitinib Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Sunitinib Drug Sales Volume Share by Application (2018-2023)
-
Table Company 1 Company Profile
-
Table Company 1 Sunitinib Drug Revenue, Price and Gross (2018-2023)
-
Table Company 2 Company Profile
-
Table Company 2 Sunitinib Drug Revenue, Price and Gross (2018-2023)
-
Table Company 3 Company Profile
-
Table Company 3 Sunitinib Drug Revenue, Price and Gross (2018-2023)
-
Table Company 4 Company Profile
-
Table Company 4 Sunitinib Drug Revenue, Price and Gross (2018-2023)
-
Table Company 5 Company Profile
-
Table Company 5 Sunitinib Drug Revenue, Price and Gross (2018-2023)
-
Table Company 6 Company Profile
-
Table Company 6 Sunitinib Drug Revenue, Price and Gross (2018-2023)
-
Table Company 7 Company Profile
-
Table Company 7 Sunitinib Drug Revenue, Price and Gross (2018-2023)
-
Table Company 8 Company Profile
-
Table Company 8 Sunitinib Drug Revenue, Price and Gross (2018-2023)
-
Table Company 9 Company Profile
-
Table Company 9 Sunitinib Drug Revenue, Price and Gross (2018-2023)
-
Table Company 10 Company Profile
-
Table Company 10 Sunitinib Drug Revenue, Price and Gross (2018-2023)
-
